Navigation Links
Atlantic Peptides, a Synthetic Peptide Manufacturer, Unveils Its New Website for Easier Navigation
Date:11/5/2013

Scarborouth, Maine (PRWEB) November 05, 2013

Atlantic Peptides, a synthetic peptide manufacturer, unveils its new website for easier navigation.

Atlantic Peptides (http://www.atlanticpeptides.com/), a synthetic peptide manufacturer and polyclonal and monoclonal antibody supplier, announces the launch of its new website. The updated site marks Atlantic Peptide’s initiative to reach an even broader national and international audience through the life-science and academia industries.

Atlantic Peptides announces the launch of its new website design, which facilitates easier user navigation. Atlantic Peptides is a synthetic peptide manufacturer and supplier of polyclonal and monoclonal antibodies to national and international academia and science industries. The Scarborough-based business also works with the pharmaceutical industries by supplying therapeutic initiatives with peptides for research studies.

The website features updated, in-depth coverage of the types of products Atlantic Peptides offers, such as custom peptides for the production of antibodies. As detailed by the new website, services also include the evaluation and analysis of peptides prior to synthesis by the use of hydrophobicity plots, evaluation of the stability and solubility of peptides, as well as the analysis of secondary structure formations, and more.

The site additionally houses an easy-to-use Peptide Library that serves as a useful resource, describing industry-relevant terms like overlapping peptide library, truncation peptide library, alanine peptide scanning library, and random peptide library for those interested in learning about term variations.

Atlantic Peptides is partnered with a United Kingdom company to provide cGMP services to support the various stages of clinical studies, from pre-clinical toxicology studies to early stage trials. The facility spans more than 10,000 square feet with eight cGMP suites, and was designed to meet and exceed national and international standards. Access-controlled facilities include a laminar flow Grade A cabinet, and built-in and walk-in fume cabinets.

About Atlantic Peptides

Atlantic Peptides manufactures synthetic peptides, as well as provides mono- and poly-clonal antibodies to the academic and life-science industries across the world. Atlantic Peptides also offers personalized, custom services to address individual business needs, and also works with pharmaceutical industries for research studies.

Read the full story at http://www.prweb.com/releases/2013/11/prweb11297124.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Atlantic Shores Retirement Community Develops Cutting-Edge Program for CCRC Patient Care
2. Keiretsu Forum Mid-Atlantic Launches July Four-City Road Show
3. MS Tûranor PlanetSolar Sets World Speed Record for Transatlantic Crossing by Solar Electric Vessel
4. Atlantic Peptides Teams Up with a United Kingdom Company to Offer cGMP Peptides and API
5. Atlantica Group LLC to Support International "Soft-Landing" Efforts of Incubators and Accelerators
6. Atlantica Group LLC to Support Global Business Incubation and "Soft Landing" Efforts
7. Air Products to Feature Medical and Industrial Grade Gas Solutions for Pharma, Biotech, and Life Science Applications at Mid-Atlantic Bio Conference
8. Human Genome Decoder and Artificial Life Creator, J. Craig Venter to Speak at "The Atlantic Meets the Pacific"
9. Lend Lease Announces the Appointment of Tom Chapman as Director Operations for the Life Sciences Group in the Atlantic Region
10. Waters Unveils Industrys First Integrated LC/MS Platform for Proteins, Peptides, and Glycans Analysis at WCBP 2013
11. Synthetic Biologics Responds to Recent CDC Report on Threat of "Super Bugs"
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... 24, 2017 Symic Bio, a biopharmaceutical company ... category of therapeutics, announced today the completion of enrollment ... artery disease. The trial will evaluate the safety and ... the reduction of restenosis following angioplasty. ... for SB-030," said Nathan Bachtell , M.D., Chief ...
(Date:2/24/2017)... Corporation (NASDAQ: VWR), the leading global independent provider of product ... its financial results for the fourth quarter and full year ... 4Q16 record quarterly net sales of $1.13 billion, up ... 4Q16 EMEA-APAC segment net sales increased ... net sales increased 2.5%, or down 0.9% on an organic ...
(Date:2/23/2017)... Feb. 23, 2017 /PRNewswire/ - The Fight Against Cancer ... Research (OICR) are pleased to report that Fusion Pharmaceuticals ... with Johnson & Johnson Innovation – JJDC, Inc. (JJDC) ... groups HealthCap, TPG Biotechnology Partners, and Genesys Capital, as ... ...
(Date:2/23/2017)... , ... February 23, 2017 , ... ... de novo clearance to begin marketing the SPEAC® System, the Brain Sentinel® Seizure ... at home or in healthcare facilities during periods of rest. A lightweight, non-invasive ...
Breaking Biology Technology:
(Date:2/8/2017)... -- Aware, Inc. (NASDAQ: AWRE ), a leading supplier ... its quarter and year ended December 31, 2016. ... million compared to $6.9 million in the same quarter last ... $0.6 million compared to $2.6 million in the fourth quarter ... was $0.5 million, or $0.02 per diluted share, which compares ...
(Date:2/8/2017)... -- Report Highlights The global biosurgery market ... in 2016 at a compound annual growth rate (CAGR) ... - An overview of the global market for biosurgery. ... 2015 and 2016, and projections of compound annual growth ... on the basis of product type, source, application, and ...
(Date:2/7/2017)... 2017 Ipsidy Inc. ( www.ipsidy.com ... IDGS], ("Ipsidy" or the "Company") a provider of secure, ... is pleased to announce the following changes as part ... January 31, 2017, Philip D. Beck was ... President.  An experienced payment industry professional and public company ...
Breaking Biology News(10 mins):